ArticleMaterials (Basel, Switzerland)2026
Research on Early-Age Shrinkage and Prediction Model of Ultra-High-Performance Concrete Based on the BO-XGBoost Algorithm.
Article in Materials (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A Review of the Effects of Supplementary Cementitious Materials on the Autogenous Shrinkage of High-Performance Concrete.Materials (Basel, Switzerland) · 2026Review
- Performance Evolution and Balance in the Curing Mechanism of Inorganic Thermal Insulation Mortar: A Review.Materials (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Early-age shrinkage is a critical factor governing the dimensional stability and cracking susceptibility of ultra-high-performance concrete (UHPC). However, accurate prediction of UHPC shrinkage remains challenging due to the strong nonlinear interactions among mixture parameters, curing conditions, and hydration-induced internal moisture evolution, particularly when only limited experimental data are available. In this study, a systematic experimental program was conducted to investigate the influence of the binder-to-sand ratio, water-to-binder ratio, polypropylene fiber dosage, and curing environment on both early drying shrinkage and autogenous shrinkage of UHPC. Based on the experimental results, a structured dataset covering all shrinkage test data was constructed to support data-driven modeling. To improve prediction reliability under small-sample conditions, a Bayesian-optimized Extreme Gradient Boosting (BO-XGBoost) framework was developed and benchmarked against several conventional machine learning models, including Backpropagation Neural Networks (BPNNs), Random Forest (RF), and Support Vector Machines (SVMs). Shrinkage test data from other literature validated the prediction accuracy of this model, demonstrating its rationality and practicality. In addition, the Shapley Additive Explanations (SHAP) method was employed to quantitatively interpret the contribution and interaction mechanisms of key variables affecting shrinkage behavior. The results show that the BO-XGBoost model achieves the highest prediction accuracy and stability among the evaluated algorithms. SHAP analysis further reveals that curing age and curing environment dominate drying shrinkage, whereas autogenous shrinkage is primarily governed by the curing age and water-to-binder ratio. The interaction analysis also identifies the coupled effects between low water-to-binder ratio and extended curing age. The proposed framework not only improves prediction robustness for UHPC shrinkage under limited data conditions but also provides interpretable insights into the mechanisms governing early-age deformation. These findings offer a data-driven basis for optimizing UHPC mixture design and mitigating early-age cracking risks in engineering applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.